(Q38410120)

English

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

scientific article published on 09 June 2015

In more languages
default values for all languages
No label defined

No description defined

Statements

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial (English)
Patrick S Parfrey
Geoffrey A Block
Ricardo Correa-Rotter
Tilman B Drüeke
Charles A Herzog
David C Wheeler
William G Goodman
Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit